Skip to content
News Center
About Us Careers News Center Contact Us Legal Video Hub Partner Programs Doing business with Illumina Investors Illumina for Startups

Corporate

Jay T. Flatley: 17 Years of Leadership

Infographic provides an overview of Illumina’s remarkable growth 1999-present

Jay T. Flatley: 17 Years of Leadership
7 March 2016

Download the PDF »

Previous Article
Next Article

Recent Articles

It’s time to unlock the next new standard of care for cancer patients
It’s time to unlock the next new standard of care for cancer patients
Liquid-based CGP is critical for matching cancer patients to therapies
Liquid-based CGP is critical for matching cancer patients to therapies
Operating a speedy, high-tech NGS lab in remote Australia
Operating a speedy, high-tech NGS lab in remote Australia
For Research Use Only

Not for use in diagnostic procedures (except as specifically noted).

Innovative technologies

At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.

All trademarks are the property of Illumina, Inc. or their respective owners.
For specific trademark information, see emea.illumina.com/company/legal.html.

© 2025 Illumina, Inc. All rights reserved.